Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infarction, Muscular Disorders, Atrophic, Necrosis, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, brain disorder, brain infarction, brain ischemia, brain stem infarction, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, injury, ischemic disease, metabolic disease, motor neuron disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, palsy, progressive muscular atrophy, proteostasis deficiencies, quadriplegia, spinal cord disorder, spinal cord injury, spinal muscular atrophy, stroke disorder, vascular disorder	Recruiting	Not applicable	2026-10-09		NCT07521930

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Blackrock Neurotech	1
JHU Applied Physics Laboratory	1
Johns Hopkins University	579
Kennedy Krieger Institute, Baltimore, MD	3

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Johns Hopkins Medicine	Baltimore	United States	6